A study of ZVex-Neo for the treatment of Non-small cell lung cancer.
Phase of Trial: Phase I
Latest Information Update: 01 Sep 2016
At a glance
- Drugs ZVex Neo (Primary)
- Indications Non-small cell lung cancer
- Focus Adverse reactions
- 01 Sep 2016 According to an Immune Design media release, the company plans to initiate this study in 2017.
- 01 Sep 2016 New trial record